サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1546204

陽子線治療の世界市場

Proton Therapy
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 193 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.76円
陽子線治療の世界市場
出版日: 2024年09月03日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

陽子線治療の世界市場は2030年までに15億米ドルに達する見込み

2023年に6億1,460万米ドルと推定される陽子線治療の世界市場は、2023年から2030年にかけてCAGR 13.5%で成長し、2030年には15億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである加速器は、CAGR13.7％を記録し、分析期間終了時には8億4,360万米ドルに達すると予測されています。ビームデリバリーシステム分野の成長率は、分析期間でCAGR 14.2％と推定されます。

米国市場は1億6,560万米ドルと推定、中国はCAGR12.5％で成長予測

米国の陽子線治療市場は、2023年に1億6,560万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGR12.5%を牽引し、2030年までに2億2,380万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ12.0%と11.2%と予測されています。欧州では、ドイツがCAGR約9.5%で成長すると予測されています。

世界の陽子線治療市場- 主要動向と促進要因のまとめ

がんを高精度で標的化成長する陽子線治療市場

陽子線治療は最先端の放射線療法であり、腫瘍をターゲットとする高精度で効果的な選択肢を提供することで、がん治療のあり方を変えつつあります。周囲の健康な組織を損傷する可能性のある従来のX線照射とは異なり、陽子線治療は荷電粒子（プロトン）を使用し、その最大エネルギーを腫瘍部位に直接照射するため、隣接する健康な細胞への付随的な損傷を最小限に抑えることができます。この精度の高さにより、陽子線治療は、脳、脊椎、目などの重要な構造物の近くに位置し、従来の放射線照射では重大な副作用を引き起こす可能性のある腫瘍の治療において、特に大きな価値を発揮します。がん治療の精度と個別化がますます重視される中、陽子線治療は、多くの患者、特に小児や複雑な症例の患者にとって、より優れた選択肢として認知されつつあります。

技術の進歩は陽子線治療をどのように強化しているのでしょうか？

技術の進歩は、陽子線治療の拡大と改良に極めて重要な役割を果たしています。MRIやCTに基づく治療計画などの画像技術の革新は、陽子線照射の精度を著しく向上させ、臨床医が腫瘍をよりよく可視化し、ピンポイントで治療計画を立てることを可能にしました。ペンシルビームスキャニング（PBS）技術の開発は、腫瘍の正確な形状に適合する高集束ビームの照射を可能にし、周囲の健康な組織への線量を低減することで、陽子線治療の精度をさらに向上させました。さらに、加速器技術の進歩により、治療施設の規模や費用が縮小され、陽子線治療がより利用しやすくなりました。このような技術の向上により、陽子線治療は世界中のがん治療センターにとって、より現実的で魅力的な選択肢となっています。

広がる陽子線治療の応用とは？

陽子線治療の幅広いがん治療への有効性を裏付ける臨床エビデンスが増えるにつれ、その用途は拡大しています。陽子線治療は、従来から小児がんや重要構造部近傍の腫瘍に使用されてきましたが、現在では、周辺組織への放射線被曝を最小限に抑えることが重要な乳がん、肺がん、消化器がんの治療への応用が検討されています。陽子線治療は、長期的な副作用を軽減し、がんサバイバーの生活の質を向上させる可能性があることから、唾液腺や声帯などの重要な臓器に大きなダメージを与える可能性のある頭頸部がんの治療にも採用されています。さらに、現在進行中の調査では、免疫療法や化学療法などの他の治療と併用することで、全体的な治療効果を高めることも研究されています。このように用途が広がることで、がん治療における陽子線治療の範囲が広がっています。

市場成長の主な促進要因は？

陽子線治療市場の成長は、いくつかの要因によってもたらされます。世界のがん罹患率の増加は、先進的で正確かつ効果的な治療オプションに対する需要が増加し続けているため、主要な促進要因となっています。イメージング、ビーム照射、加速器設計の技術的進歩により、陽子線治療の利用しやすさと有効性が大幅に改善され、治療センターにとってより魅力的な選択肢となっています。陽子線治療で治療可能ながんの範囲が広がっていることと、その利点を裏付ける臨床的エビデンスが増えていることも、採用を後押ししています。さらに、個別化医療や精密医療への注目の高まりは、特に従来の放射線治療が大きな副作用を引き起こす可能性のある症例において、陽子線治療の使用を後押ししています。世界のヘルスケアコミュニティが患者中心の医療を優先し続ける中、陽子線治療の需要は大幅に伸びると予想されます。

調査対象企業の例（全43件）

  • Advanced Oncotherapy Plc
  • Hitachi Ltd.
  • Ion Beam Applications SA
  • Koninklijke Philips NV
  • Mevion Medical Systems, Inc.
  • Mitsubishi Corporation
  • Optivus Proton Therapy, Inc.
  • Protom International
  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP14268

Global Proton Therapy Market to Reach US$1.5 Billion by 2030

The global market for Proton Therapy estimated at US$614.6 Million in the year 2023, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 13.5% over the analysis period 2023-2030. Accelerators, one of the segments analyzed in the report, is expected to record a 13.7% CAGR and reach US$843.6 Million by the end of the analysis period. Growth in the Beam Delivery Systems segment is estimated at 14.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$165.6 Million While China is Forecast to Grow at 12.5% CAGR

The Proton Therapy market in the U.S. is estimated at US$165.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$223.8 Million by the year 2030 trailing a CAGR of 12.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.0% and 11.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.5% CAGR.

Global Proton Therapy Market - Key Trends and Drivers Summarized

Targeting Cancer with Precision: The Growing Market for Proton Therapy

Proton therapy is a cutting-edge form of radiation therapy that is transforming the way cancer is treated, offering a highly precise and effective option for targeting tumors. Unlike conventional X-ray radiation, which can damage surrounding healthy tissues, proton therapy uses charged particles (protons) that deliver their maximum energy directly to the tumor site, minimizing collateral damage to adjacent healthy cells. This precision makes proton therapy particularly valuable in treating tumors located near critical structures, such as the brain, spine, and eyes, where conventional radiation could cause significant side effects. As cancer treatment becomes increasingly focused on precision and personalized care, proton therapy is gaining recognition as a superior option for many patients, especially children and those with complex cases.

How Are Technological Advancements Enhancing Proton Therapy?

Technological advancements have played a pivotal role in the expansion and improvement of proton therapy. Innovations in imaging technologies, such as MRI and CT-based planning, have significantly enhanced the accuracy of proton beam delivery, allowing clinicians to better visualize tumors and plan treatments with pinpoint precision. The development of pencil beam scanning (PBS) technology has further improved the precision of proton therapy by enabling the delivery of highly focused beams that can conform to the exact shape of the tumor, reducing the dose to surrounding healthy tissues. Additionally, advancements in accelerator technology have made proton therapy more accessible by reducing the size and cost of treatment facilities. These technological improvements are making proton therapy a more viable and attractive option for cancer treatment centers around the world.

What Are the Expanding Applications of Proton Therapy?

The applications of proton therapy are expanding as more clinical evidence supports its efficacy in treating a wide range of cancers. While traditionally used for pediatric cancers and tumors near critical structures, proton therapy is now being explored for use in treating breast, lung, and gastrointestinal cancers, where minimizing radiation exposure to surrounding tissues is crucial. The potential for proton therapy to reduce long-term side effects and improve the quality of life for cancer survivors is also driving its adoption in the treatment of head and neck cancers, where traditional radiation can cause significant damage to critical organs such as the salivary glands and vocal cords. Additionally, ongoing research is investigating the use of proton therapy in combination with other treatments, such as immunotherapy and chemotherapy, to enhance overall treatment outcomes. These expanding applications are broadening the scope of proton therapy in cancer care.

What Are the Key Growth Drivers in the Market?

The growth in the proton therapy market is driven by several factors. The increasing incidence of cancer worldwide is a major driver, as the demand for advanced, precise, and effective treatment options continues to rise. Technological advancements in imaging, beam delivery, and accelerator design have significantly improved the accessibility and efficacy of proton therapy, making it a more attractive option for treatment centers. The expanding range of cancers that can be treated with proton therapy, coupled with the growing body of clinical evidence supporting its benefits, is also driving adoption. Additionally, the increasing focus on personalized and precision medicine is encouraging the use of proton therapy, particularly in cases where traditional radiation could cause significant side effects. As the global healthcare community continues to prioritize patient-centered care, the demand for proton therapy is expected to grow substantially.

Select Competitors (Total 43 Featured) -

  • Advanced Oncotherapy Plc
  • Hitachi Ltd.
  • Ion Beam Applications SA
  • Koninklijke Philips NV
  • Mevion Medical Systems, Inc.
  • Mitsubishi Corporation
  • Optivus Proton Therapy, Inc.
  • Protom International
  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Proton Therapy - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cancer Propels Market Growth
    • Increasing Adoption of Advanced Radiation Therapies Expands Addressable Market Opportunity
    • Technological Advancements in Proton Therapy Systems Strengthen Market Position
    • Growing Focus on Precision Medicine Drives Adoption of Proton Therapy
    • Surge in Demand for Non-Invasive Cancer Treatments Generates New Opportunities
    • Development of Compact and Affordable Proton Therapy Systems Sustains Market Growth
    • Expanding Applications in Pediatric Oncology Throws Spotlight on Market Potential
    • Growth in Global Healthcare Infrastructure Spurs Demand for Proton Therapy
    • Rising Awareness of Proton Therapy's Advantages Over Traditional Radiation Propels Market Expansion
    • Surge in Demand from Emerging Markets Expands Market Horizons
    • Innovations in Image-Guided Proton Therapy Generate New Market Opportunities
    • Increasing Reimbursement Support for Proton Therapy Treatments Accelerates Market Growth
    • Rising Number of Proton Therapy Centers Worldwide Throws Spotlight on Market Dynamics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Proton Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Proton Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Proton Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Proton Therapy Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Accelerators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Accelerators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Accelerators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Beam Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Beam Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Beam Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Beam Transport Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Beam Transport Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Beam Transport Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for CNS Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for CNS Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for CNS Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Prostate Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Head & Neck Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Head & Neck Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Head & Neck Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Proton Therapy Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Proton Therapy Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Proton Therapy Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: China 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Proton Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Proton Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Proton Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: France 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of World 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Rest of World 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION